Gene · 6385
Papers3,062
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,062
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyclic increase in the ADAMTS1-L1CAM-EGFR axis promotes the EMT and cervical lymph node metastasis of oral squamous cell carcinoma. | Cell Death Dis | 2024 | 38263290 | PubTator, text mining | PubMed |
| In-Hospital Levels of Circulating MicroRNAs as Potential Predictors of Left Ventricular Remodeling Post-Myocardial Infarction. | Medicina (Kaunas) | 2024 | 38256409 | PubTator, text mining | PubMed |
| Association between syndecan-4 and subclinical atherosclerosis in ankylosing spondylitis. | Medicine (Baltimore) | 2024 | 38241528 | PubTator, text mining | PubMed |
| Single-cell RNA-Seq Elucidates the Crosstalk Between Cancer Stem Cells and the Tumor Microenvironment in Hepatocellular Carcinoma. | J Cancer | 2024 | 38230205 | PubTator, text mining | PubMed |
| Bioinformatics-based discovery of intervertebral disc degeneration biomarkers and immune-inflammatory infiltrates. | JOR Spine | 2024 | 38222811 | PubTator, text mining | PubMed |
| CardiOmics signatures reveal therapeutically actionable targets and drugs for cardiovascular diseases. | Heliyon | 2024 | 38187312 | PubTator, text mining | PubMed |
| Author Correction: Systemically administered wound-homing peptide accelerates wound healing by modulating syndecan-4 function. | Nat Commun | 2024 | 38172142 | PubTator, text mining | PubMed |
| Different effects of crizotinib treatment in two non-small cell lung cancer patients with SDC4::ROS1 fusion variants. | Thorac Cancer | 2024 | 38093515 | PubTator, text mining | PubMed |
| CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations. | J Thorac Oncol | 2024 | 38070598 | PubTator, text mining | PubMed |
| Soluble vascular endothelial glycocalyx proteoglycans as potential therapeutic targets in inflammatory diseases. | Immunol Cell Biol | 2024 | 37982607 | PubTator, text mining | PubMed |
| Low expression of ZFP36L1 in osteosarcoma promotes lung metastasis by inhibiting the SDC4-TGF-β signaling feedback loop. | Oncogene | 2024 | 37935976 | PubTator, text mining | PubMed |
| MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling. | Mol Cancer Ther | 2024 | 37748191 | PubTator, text mining | PubMed |
| RSPO2 as Wnt signaling enabler: Important roles in cancer development and therapeutic opportunities. | Genes Dis | 2024 | 37692504 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing in juvenile idiopathic arthritis. | Genes Dis | 2024 | 37692495 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the evolution of immune molecules across multiple vertebrate species. | J Adv Res | 2024 | 36871615 | PubTator, text mining | PubMed |
| PCR Array Profiling of miRNA Expression Involved in the Differentiation of Amniotic Fluid Stem Cells toward Endothelial and Smooth Muscle Progenitor Cells. | Int J Mol Sci | 2023 | 38203477 | PubTator, text mining | PubMed |
| Chitosan-Based Dressing as a Sustained Delivery System for Bioactive Cytokines. | Int J Mol Sci | 2023 | 38203201 | PubTator, text mining | PubMed |
| An Overview of Growth Factors as the Potential Link between Psoriasis and Metabolic Syndrome. | J Clin Med | 2023 | 38202116 | PubTator, text mining | PubMed |
| KLC1-ROS1 Fusion Exerts Oncogenic Properties of Glioma Cells via Specific Activation of JAK-STAT Pathway. | Cancers (Basel) | 2023 | 38201436 | PubTator, text mining | PubMed |
| Progress of non-small-cell lung cancer with ROS1 rearrangement. | Front Mol Biosci | 2023 | 38187090 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6385/papers?page=11